cardiotocography

• 胎児心拍陣痛図

関

cardiotocogram、cardiotocograph

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/03/06 02:24:20」(JST)

wiki en

[Wiki en表示]

Cardiotocography
Intervention
A cardiotocograph recording fetal heart rate and uterine contractions
ICD-9-CM	75.32
MeSH	D015148

In medicine (obstetrics), cardiotocography (CTG) is a technical means of recording (-graphy) the fetal heartbeat (cardio-) and the uterine contractions (-toco-) during pregnancy, typically in the third trimester. The machine used to perform the monitoring is called a cardiotocograph, more commonly known as an electronic fetal monitor (EFM).

The invasive fetal monitoring was invented by Doctors Alan Bradfield, Orvan Hess and Edward Hon. A refined (antepartal, non-invasive, beat-to-beat) version (cardiotocograph) was later developed for Hewlett Packard by Dr. Konrad Hammacher.

Method

Schematic explanation of cardiotocography: heart rate (A) is calculated from fetal heart motion determined by ultrasound, and uterine contractions are measured by a tocodynamometer (B). These numbers are represented on a time scale with the help of a running piece of paper, producing a graphical representation.

Simultaneous recordings are performed by two separate transducers, one for the measurement of the fetal heart rate and a second one for the uterine contractions. Each of the transducers may be either external or internal.

External measurement means taping or strapping the two sensors to the abdominal wall. The heart (cardio) sensor is a ultrasonic sensor, similar to a Doppler fetal monitor, that continuously emits ultrasound and detects motion of the fetal heart by the characteristic of the reflected sound. The pressure-sensitive contraction transducer, called a tocodynamometer (toco) has a flat area that is fixated to the skin by a band around the belly. The pressure required to flatten a section of the wall correlates with the internal pressure, thereby providing an estimate of it.

Internal measurement requires a certain degree of cervical dilatation, as it involves inserting a pressure catheter into the uterine cavity, as well as attaching a scalp electrode to the fetal head to adequately measure the electric activity of the fetal heart. Internal measurement is more precise, and might be preferable when a complicated childbirth is expected.

A typical CTG reading is printed on paper and/or stored on a computer for later reference. Use of CTG and a computer network, allows continual remote surveillance: a single obstetrical nurse, midwife, or obstetrician can watch the CTG traces of multiple patients simultaneously, via a computer station.

Interpretation

A typical CTG output for a woman not in labour. A: Fetal heartbeat; B: Indicator showing movements felt by mother (caused by pressing a button); C: Fetal movement; D: Uterine contractions

In the US, the Eunice Kennedy Shriver National Institute of Child Health and Human Development sponsored a workshop to develop a standardized nomenclature for use in interpreting intrapartum fetal heart rate and uterine contraction patterns. This nomenclature has been adopted by the Association of Women’s Health, Obstetric, and Neonatal Nurses (AWHONN), the American College of Obstetricians and Gynecologists (ACOG), and the Society for Maternal-Fetal Medicine.

The Royal College of Obstetricians and Gynaecologists and the Society of Obstetricians and Gynaecologists of Canadahave also published consensus statements on standardized nomenclature for fetal heart rate patterns.

Interpretation of a CTG tracing requires both qualitative and quantitative description of:

• Uterine activity (contractions)
• Baseline fetal heart rate (FHR)
• Baseline FHR variability
• Presence of accelerations
• Periodic or episodic decelerations
• Changes or trends of FHR patterns over time.

Uterine activity

There are several factors used in assessing uterine activity.

• Frequency- the amount of time between the start of one contraction to the start of the next contraction.
• Duration- the amount of time from the start of a contraction to the end of the same contraction.
• Intensity- a measure of how strong a contraction is. With external monitoring, this necessitates the use of palpation to determine relative strength. With an IUPC, this is determined by assessing actual pressures as graphed on the paper.
• Resting Tone- a measure of how relaxed the uterus is between contractions. With external monitoring, this necessitates the use of palpation to determine relative strength. With an IUPC, this is determined by assessing actual pressures as graphed on the paper
• Interval- the amount of time between the end of one contraction to the beginning of the next contraction.

The NICHD nomenclature defines uterine activity by quantifying the number of contractions present in a 10-minute window, averaged over 30 minutes. Uterine activity may be defined as:

• Normal- less than or equal to 5 contractions in 10 minutes, averaged over a 30-minute window
• Tachysystole- more than 5 contractions in 10 minutes, averaged over a 30-minute window

Baseline fetal heart rate

The NICHD nomenclature defines baseline fetal heart rate as: The baseline FHR is determined by approximating the mean FHR rounded to increments of 5 beats per minute (bpm) during a 10-minute window, excluding accelerations and decelerations and periods of marked FHR variability (greater than 25 bpm). There must be at least 2 minutes of identifiable baseline segments (not necessarily contiguous) in any 10-minute window, or the baseline for that period is indeterminate. In such cases, it may be necessary to refer to the previous 10-minute window for determination of the baseline. Abnormal baseline is termed bradycardia when the baseline FHR is less than 110 bpm; it is termed tachycardia when the baseline FHR is greater than 160 bpm.

Baseline FHR variability

The NICHD nomenclature defines baseline FHR variability as: Baseline FHR variability is determined in a 10-minute window, excluding accelerations and decelerations. Baseline FHR variability is defined as fluctuations in the baseline FHR that are irregular in amplitude and frequency. The fluctuations are visually quantitated as the amplitude of the peak-to-trough in bpm. Using this definition, the baseline FHR variability is categorized by the quantitated amplitude as:

• Absent- undetectable
• Minimal- greater than undetectable, but less than or equal to 5 bpm
• Moderate- 6-25 bpm
• Marked- greater than 25 bpm

Accelerations

The NICHD nomenclature defines an acceleration as a visually apparent abrupt increase in FHR. An abrupt increase is defined as an increase from the onset of acceleration to the peak in less than or equal to 30 seconds. To be called an acceleration, the peak must be greater than or equal to 15 bpm, and the acceleration must last greater than or equal to 15 seconds from the onset to return. A prolonged acceleration is greater than or equal to 2 minutes but less than 10 minutes in duration. An acceleration lasting greater than or equal to 10 minutes is defined as a baseline change. Before 32 weeks of gestation, accelerations are defined as having a peak greater than or equal to 10 bpm and a duration of greater than or equal to 10 seconds.

Periodic or episodic decelerations

Periodic refers to decelerations that are associated with contractions; episodic refers to those not associated with contractions. There are four types of decelerations as defined by the NICHD nomenclature.

• Early Deceleration: Visually apparent, usually symmetrical, gradual decrease and return of the FHR associated with a uterine contraction. A gradual FHR decrease is defined as one from the onset to the FHR nadir of greater than or equal to 30 seconds. The decrease in FHR is calculated from the onset to the nadir of the deceleration. The nadir of the deceleration occurs at the same time as the peak of the contraction. In most cases the onset, nadir, and recovery of the deceleration are coincident with the beginning, peak, and ending of the contraction, respectively
• Late Deceleration: Visually apparent usually symmetrical gradual decrease and return of the FHR associated with a uterine contraction. A gradual FHR decrease is defined as from the onset to the FHR nadir of greater than or equal to 30 seconds. The decrease in FHR is calculated from the onset to the nadir of the deceleration. The deceleration is delayed in timing, with the nadir of the deceleration occurring after the peak of the contraction. In most cases, the onset, nadir, and recovery of the deceleration occur after the beginning, peak, and ending of the contraction, respectively.
• Variable Deceleration: Visually apparent abrupt decrease in FHR. An abrupt FHR decrease is defined as from the onset of the deceleration to the beginning of the FHR nadir of less than 30 seconds. The decrease in FHR is calculated from the onset to the nadir of the deceleration. The decrease in FHR is greater than or equal to 15 beats per minute, lasting greater than or equal to 15 seconds, and less than 2 minutes in duration. When variable decelerations are associated with uterine contractions, their onset, depth, and duration commonly vary with successive uterine contractions.
• Prolonged Deceleration: A prolonged deceleration is present when there is a visually apparent decrease in FHR from the baseline that is greater than or equal to 15 bpm, lasting greater than or equal to 2 minutes, but less than 10 minutes. A deceleration that lasts greater than or equal to 10 minutes is a baseline change.

Additionally decelerations can be recurrent or intermittent based on their frequency (more or less than 50% of the time) within a 20 min window.

FHR pattern classification

The NICHD workgroup proposed terminology of a three-tiered system to replace the older undefined terms "reassuring" and "nonreassuring".

• Category I (Normal): Tracings with all these findings present are strongly predictive of normal fetal acid-base status at the time of observation and the fetus can be followed in a standard manner:
  • Baseline rate 110-160 bpm,
  • Moderate variability,
  • Absence of late, or variable decelerations,
  • Early decelerations and accelerations may or may not be present.

• Category II (Indeterminate): Tracing is not predictive of abnormal fetal acid-base status, but evaluation and continued surveillance and reevaluations are indicated.
  • Bradycardia not accompanied by absent baseline variability
  • Tachycardia
  • Minimal or Marked baseline variability of FHR
  • Accelerations: Absence of induced accelerations after fetal stimulation
  • Periodic or Episodic decelerations: Longer than 2min but shorter than 10min; Recurrent late decelerations with moderate baseline variability
  • Variable decelerations with other characteristics such as slow return to baseline, overshoots of "shoulders" seen (humps on either side of deceleration)

• Category III (Abnormal): Tracing is predictive of abnormal fetal acid-base status at the time of observation; this requires prompt evaluation and management:
  • Absence of baseline variability with recurrent late or variable decelerations or bradycardia; or
  • Sinusoidal fetal heart rate.

Effect on management

A Cochrane Collaboration review has shown that use of cardiotocography reduces the rate of seizures in the newborn but not the types of seizures that do long term damage, and there is no clear benefit in the prevention of cerebral palsy, perinatal death and other complications of labour. In contrast, labour monitored by CTG is slightly more likely to result in instrumental delivery (forceps or vacuum extraction) or Cesarean section. The false-positive rate of cardiotocography for cerebral palsy is given as high as 99%, meaning that only 1-2 of one hundred babies with non-reassuring patterns will develop cerebral palsy. The introduction of additional methods of intrapartum assessment has given mixed results.

When introduced, this practice was expected to reduce the incidence of fetal demise in labor and make for a reduction in cerebral palsy (CP). Its use became almost universal for hospital births in the U.S. In recent years there has been some controversy as to the utility of the cardiotocograph in low-risk pregnancies, and the related belief that over-reliance on the test has led to increased misdiagnoses of fetal distress and hence increased (and possibly unnecessary) cesarean deliveries.

Manufacturer

The popular manufacturers are GE (Corometrics), Philips (HP), Huntleigh (Sonicaid), Analogic, Ultrasound Technologies (Seward/Wakeling), Toitu, Sunray, Edan and Neoventa.

References

See also

• Fetal stethoscope
• Nonstress test (NST)
• Biophysical profile (BPP)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 分娩時胎児心拍数の評価 intrapartum fetal heart rate assessment
• 2. ノンストレス検査および収縮ストレス検査 nonstress test and contraction stress test
• 3. 胎児の発育遅延：評価およびマネージメント fetal growth restriction evaluation and management
• 4. 臍帯巻絡 nuchal cords
• 5. 外回転術 external cephalic version

English Journal

• Comparison of the effect of different sampling modes on computer analysis of cardiotocograms.

• Gonçalves H1, Chaves J2, Costa A3, Ayres-de-Campos D4, Bernardes J5.
• Computers in biology and medicine.Comput Biol Med.2015 Sep 1;64:62-6. doi: 10.1016/j.compbiomed.2015.06.011. Epub 2015 Jun 24.
• BACKGROUND: Cardiotocographic (CTG) monitors may provide fetal heart rate (FHR) signals as beat-to-beat (BTB) or alternatively at a fixed sampling rate. The aim of this study was to assess the effect of different sampling modes on the evaluation provided by a commercially available system for comput
• PMID 26143523

• Maternal Glycemia and Fetal Well-Being: Continuous Glucose Monitoring and Continuous Cardiotocography.

• Murphy HR1.
• Diabetes technology & therapeutics.Diabetes Technol Ther.2015 Sep;17(9):603-4. doi: 10.1089/dia.2015.0167. Epub 2015 Jun 4.
• PMID 26317879

• Categorization of Fetal Heart Rate Decelerations in American and European Practice: Importance and Imperative of Avoiding Framing and Confirmation Biases.

• Sholapurkar SL1.
• Journal of clinical medicine research.J Clin Med Res.2015 Sep;7(9):672-80. doi: 10.14740/jocmr2166w. Epub 2015 Jul 24.
• Interpretation of electronic fetal monitoring (EFM) remains controversial and unsatisfactory. Fetal heart rate (FHR) decelerations are the commonest aberrant feature on cardiotocographs and considered "center-stage" in the interpretation of EFM. A recent American study suggested that the lack of cor
• PMID 26251680

Japanese Journal

• 重症母児間輸血症候群の3例:─転帰良好症例と死亡症例の比較検討─

• 邨田 裕子,佐藤 浩,山田 一貴,今井 更衣子,川原村 加奈子,濱西 正三,廣瀬 雅哉
• 産婦人科の進歩 66(4), 367-375, 2014
• 　重症母児間輸血症候群の3例について，転帰良好であった2例と，児が死亡した1例を報告し，予後に関与する要因等について検討した．症例1は29歳初産婦で，37週5日に2日前からの胎動消失，および胎児心拍モニタリングでサイナソイダルパターンと遅発一過性徐脈を認め，当院へ母体搬送された．緊急帝王切開術にて2962g，Apgar score 2点/5点（1分後/5分後）の男児を娩出した．児は血中ヘモグロビン …
• NAID 130004704275

• 妊娠中に発症した絞扼性イレウスの2例:─本邦報告58例の検討─

• 香川 哲也,香川 幸子
• 日本腹部救急医学会雑誌 34(1), 147-151, 2014
• 当院で経験した妊娠中の絞扼性イレウス4例のうち2例を呈示する。症例1：34歳，妊娠29週，初妊婦。突然の上腹部痛・頻回嘔吐にて救急外来を受診した。糞便性イレウスの診断で入院したが，母体症状悪化に伴い胎児の高度遅発一過性徐脈が出現したため，緊急帝王切開を行った。回腸に壊死を認め切除した。児はNICUで加療したが軽快した。症例2：39歳，妊娠38週，経産婦。急激に発症した上腹部痛にて救急搬送された。腹 …
• NAID 130004679048

• Utility of Intraoperative Fetal Heart Rate Monitoring for Cerebral Arteriovenous Malformation Surgery during Pregnancy

• FUKUDA Kenji,MASUOKA Jun,TAKADA Shigeki,KATSURAGI Shinji,IKEDA Tomoaki,IIHARA Koji
• Neurologia medico-chirurgica 54(10), 819-823, 2014
• … In one case in her third trimester, cardiotocography was used. …
• NAID 130004448347

Related Links

• Cardiotocography - World News

Electronic Fetal Monitoring, CardioTocoGraphy, Fetal Heart Strip Tutorial, Maternity: Fetal Monitoring, The Fetal Brain-Fetal Heart Relationship, Intro to Fetal Heart Tracings - Baseline (03 of 11), CTG (Cardiotocography)_Fina.3gp

• cardiotocographyの意味・用例｜英辞郎 on the WEB：アルク

cardiotocography 【名】カーディオトコグラフィー、分娩[胎児の心拍]監視 陣... - アルクがお届けする進化するオンライン英和・和英辞書データベース。一般的な単語や連語から、イディオム、専門用語、スラングまで幅広く収録。